Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.
2.

Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa.

Tondella ML, Rosenstein NE, Mayer LW, Tenover FC, Stocker SA, Reeves MW, Popovic T.

Emerg Infect Dis. 2001 Jan-Feb;7(1):163-4. No abstract available.

3.

Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA.

Clin Infect Dis. 2000 Jan;30(1):212-3. No abstract available.

PMID:
10619761
4.
5.

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, McAllister SK, Clark NC, Hiramatsu K.

J Clin Microbiol. 1998 Apr;36(4):1020-7. Erratum in: J Clin Microbiol 1998 Jul;36(7):2167.

6.
7.

Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group.

Jackson LA, Tenover FC, Baker C, Plikaytis BD, Reeves MW, Stocker SA, Weaver RE, Wenger JD.

J Infect Dis. 1994 Feb;169(2):438-41.

PMID:
8106779
9.

Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agents.

Thornsberry C, Swenson JM, Baker CN, McDougal LK, Stocker SA, Hill BC.

Diagn Microbiol Infect Dis. 1988 Mar;9(3):139-53. No abstract available.

PMID:
3396302
10.

Evaluation of the MicroScan antimicrobial susceptibility system with the autoSCAN-4 automated reader.

Baker CN, Stocker SA, Rhoden DL, Thornsberry C.

J Clin Microbiol. 1986 Jan;23(1):143-8.

Supplemental Content

Loading ...
Support Center